Skip to main content
Fig. 6 | Radiation Oncology

Fig. 6

From: The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy

Fig. 6

The isodose distributions of patients with cervical cancer treated by VAMT and Tomotherapy. The isodose distributions for a a T2N0 patient treated with volumetric modulated arc therapy and b a T3N0 patient treated with tomotherapy. The thick brown and light blue lines represented the border of rectum and bladder, respectively. The thin red, pink, light blue, orange, green lines represented the dose curves of 54, 50.4, 48, 43.2 and 37.8 Gy, respectively. Tomotherapy provided significantly less rectal volume exposed to 37.8 Gy

Back to article page